Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracervical block with ropivacaine for pain relief in second trimester medical abortion
2025-524599-52-03Phase 3Authorised
- Sponsor
- Karolinska Institutet
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Induced Abortion (TOP) comparing Ropivacaine paracervical block with Placebo paracervical block (2 arms). Primary endpoint: Maximum pain score during procedure. Planned start Jul 2026; status: authorised.
02
Drugs
ropivacaine
03
Conditions
Induced Abortion (TOP)
Beyond the preview
Go deeper on 2025-524599-52-03.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524599-52-03.